Evaluation of the Efficacy of the Individually Adjusted Therapy Scale (ATI) on the Addiction Severity

Last updated: March 30, 2022
Sponsor: University Hospital, Bordeaux
Overall Status: Active - Recruiting

Phase

N/A

Condition

Stimulant Use Disorder

Opioid Use Disorder

Kleptomania

Treatment

N/A

Clinical Study ID

NCT03606759
CHUBX 2014/43
  • Ages > 18
  • All Genders

Study Summary

The management of the craving is a key element in addiction treatment as the craving is linked to the probability of relapse. Several cues could induce the craving, some generic substance-induced cues or addictive behavior-related cues (e.g. gambling-related cues), and also some more subject-specific cues. The awareness of the craving intensity and its individual cues for each patient will allow the clinician to tailor a better treatment. The aim of this study is to evaluate the efficacy of a program based on an Individually Adjusted Therapy scale added to a treatment as usual for the treatment of addiction.

Eligibility Criteria

Inclusion

Inclusion criteria:

  • 18 years old or older
  • Meet DSM-5 substance use disorder diagnosis for at least one substance (alcohol,tobacco, cannabis, opiates, cocaine) or gambling disorder currently not stabilized
  • Seek treatment for this a substance use disorder or gambling disorder
  • Beginning (or re-initiating) multi-month outpatient care for this disorder in one ofthe inclusion centres.
  • Ability to identify a priority substance/behavior, as main object of treatment, incase of simultaneous treatment on several addictions
  • Beneficiary of the French Social Security system
  • Give an informed consent to participate

Exclusion

o Exclusion criteria:

  • Severe physical or psychiatric or addictologic condition that prevents an outpatienttreatment
  • Severe physical or psychiatric condition that prevents to complete the assessment
  • Addictive disorder that requires several treatment for several substance use disordersimultaneously
  • Difficulty to understand and to write French
  • Could not be reachable by phone
  • Participate to another study that prevents to participate to another research
  • Prisoner
  • Person under law protection
  • Person under legal guardianship

Study Design

Total Participants: 484
Study Start date:
July 31, 2019
Estimated Completion Date:
April 30, 2023

Study Description

Addiction is one of the most prevalent psychiatric disorders in general population. In the DSM-5, substance abuse and substance dependence have been combined into a single substance use disorder and gambling disorder is now reclassified in the new substance-related and addictive disorders category. Moreover, a criterion assessing the craving has been added. The management of craving is an important focus of addiction treatment as craving is often linked to relapse. Several cues could precipitate the craving. Some of them are substance-related or gambling-related, some other are more person-specific. Recent studies have revealed that those "individual cues" are highly predictive of craving and relapse, and suggest that they are involved in addiction chronicity. The awareness of these cues and the intensity of the craving are important to tailor a better treatment adapted to the patient's need in order to prevent relapse. The aim of this study is to evaluate the efficacy of a program that includes an Individually Adjusted Therapy scale (ATI) to help the clinician to modulate the level of care regarding of the patient's risk of relapse (based on cues, intensity and frequency of the craving). The study will consist in a randomized controlled trial comparing 2 groups of participants that are seeking treatment for substance use disorder (alcohol, opiates, tobacco, cannabis, cocaine) or gambling disorder in an outpatient addiction clinics in France (four inclusion sites).

All the participants will be assessed with several questionnaires that evaluate the history and the severity of addiction.

Connect with a study center

  • Centre de Soin d'Accompagnement et de Prévention en Addictologie (CSAPA) BIZIA

    Bayonne, 34 100
    France

    Site Not Available

  • Bordeaux University Hospital

    Bordeaux, 33076
    France

    Site Not Available

  • Centre Hospitalier Charles Perrens

    Bordeaux, 33076
    France

    Active - Recruiting

  • Centre Hospitalier Esquirol

    Limoges, 87 025
    France

    Site Not Available

  • Centre Hospitalier Universitaire La Réunion

    Saint-Denis, 97 405
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.